Plain-English translation of NCT06294925 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study of , a medication designed to help people with moderate to severe ulcerative colitis — a condition causing lasting inflammation and ulcers in the colon and rectum. Your doctor will prescribe the medication as part of your regular care, and the research team will track how well it works for you by comparing your symptoms before and after starting treatment. You'll answer health questions online regularly over the course of one year.
Ulcerative colitis is a serious condition that can greatly affect daily life, and doctors need better information about how this medication performs in real patients over time — not just in controlled clinical settings.
You likely qualify if…
You likely don't qualify if…
You'll take as prescribed by your doctor and continue visiting your doctor as you normally would — there are no extra clinic visits required just for the study. Over 52 weeks plus a 28-day safety follow-up period, you'll complete health questionnaires regularly using your phone, tablet, or computer to report how you're feeling, your symptoms, and your quality of life. The research team will compare your disease activity before and after starting the medication to see how well it's working for you.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Canada